Publications by authors named "Petri Bono"

71Publications

Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours.

Authors:
Petri Bono Christophe Massard Katriina J Peltola Analía Azaro Antoine Italiano Rebecca S Kristeleit Giuseppe Curigliano Ulrik Lassen Hendrik-Tobias Arkenau Pasi Hakulinen Chris Garratt Tarja Ikonen Mika V J Mustonen Jordi A Rodon

ESMO Open 2020 12;5(6)

Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article and Find Full Text PDF
December 2020

First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.

Authors:
Malaka Ameratunga Irene Braña Petri Bono Sophie Postel-Vinay Ruth Plummer John Aspegren Timo Korjamo Amir Snapir Johann S de Bono

Br J Cancer 2020 Dec 29;123(12):1730-1736. Epub 2020 Sep 29.

The Institute of Cancer Research and Royal Marsden, London, UK.

View Article and Find Full Text PDF
December 2020

Comparing modular and personal service delivery in specialised outpatient care: A survey of haematology and oncology patient preferences.

Authors:
Katariina Silander Paulus Torkki Antti Peltokorpi Maija Tarkkanen Aino Lepäntalo Johanna Mattson Petri Bono Minna Kaila

Health Serv Manage Res 2019 11 12;32(4):209-217. Epub 2019 Aug 12.

2 University of Helsinki, Helsinki, Finland.

View Article and Find Full Text PDF
November 2019

Erratum to 'Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma' [Eur J Cancer 108 (February 2019) 33-40].

Authors:
Marie Auvray Edouard Auclin Philippe Barthelemy Petri Bono Pirkko Kellokumpu-Lehtinen Marine Gross-Goupil Guillermo De Velasco Thomas Powles Guillaume Mouillet Yann-Alexandre Vano Gwenaëlle Gravis Loïc Mourey Franck Priou Frédéric Rolland Bernard Escudier Laurence Albiges

Eur J Cancer 2019 Sep 11;119:200-201. Epub 2019 Jul 11.

Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address:

View Article and Find Full Text PDF
September 2019

Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma.

Authors:
Giuseppe Procopio Aristotelis Bamias Manuela Schmidinger Robert Hawkins Angel Rodriguez Sánchez Sergio Vázquez Estevez Narayanan Srihari Haralabos Kalofonos Petri Bono Chaitali Babanrao Pisal Yulia Hirschberg Luca Dezzani Qasim Ahmad Cristina Suárez Rodriguez Eric Jonasch

Clin Genitourin Cancer 2019 06;17(3):e526-e533

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
June 2019

Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results.

Authors:
Padmanee Sharma Arlene Siefker-Radtke Filippo de Braud Umberto Basso Emiliano Calvo Petri Bono Michael A Morse Paolo A Ascierto Jose Lopez-Martin Peter Brossart Kristoffer Rohrberg Begoña Mellado Bruce S Fischer Stephanie Meadows-Shropshire Abdel Saci Margaret K Callahan Jonathan Rosenberg

J Clin Oncol 2019 07 17;37(19):1608-1616. Epub 2019 May 17.

14 Memorial Sloan Kettering Cancer Center, New York, NY.

View Article and Find Full Text PDF
July 2019

Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).

Authors:
Manuela Schmidinger Aristotelis Bamias Giuseppe Procopio Robert Hawkins Angel Rodriguez Sanchez Sergio Vázquez Narayanan Srihari Haralabos Kalofonos Petri Bono Chaitali Babanrao Pisal Yulia Hirschberg Luca Dezzani Qasim Ahmad Eric Jonasch

Oncologist 2019 04 13;24(4):491-497. Epub 2019 Mar 13.

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
April 2019

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma.

Authors:
Marie Auvray Edouard Auclin Philippe Barthelemy Petri Bono Pirkko Kellokumpu-Lehtinen Marine Gross-Goupil Guillermo De Velasco Thomas Powles Guillaume Mouillet Yann-Alexandre Vano Gwenaëlle Gravis Loïc Mourey Franck Priou Frédéric Rolland Bernard Escudier Laurence Albiges

Eur J Cancer 2019 02 5;108:33-40. Epub 2019 Jan 5.

Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address:

View Article and Find Full Text PDF
February 2019

ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer.

Authors:
Katriina J Peltola Petri Bono Robert Hugh Jones Egils Vjaters Pirjo Nykänen Annamari Vuorela Riikka Oksala Pasi Pohjanjousi Mika V J Mustonen Karim Fizazi Christophe Massard

Eur Urol Focus 2020 01 5;6(1):63-70. Epub 2018 Sep 5.

Drug Development Department (DITEP), Inserm Unit U981, Université Paris Saclay, Université Paris-Sud, Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF
January 2020

p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial.

Authors:
Jeff Sperinde Weidong Huang Aki Vehtari Ahmed Chenna Pirkko-Liisa Kellokumpu-Lehtinen John Winslow Petri Bono Yolanda S Lie Christos J Petropoulos Jodi Weidler Heikki Joensuu

Clin Cancer Res 2018 07 13;24(13):3046-3052. Epub 2018 Mar 13.

Department of Oncology, Helsinki University Hospital & Helsinki University, Helsinki, Finland.

View Article and Find Full Text PDF
July 2018

Cancer costs and outcomes for common cancer sites in the Finnish population between 2009-2014.

Authors:
Paulus Torkki Riikka-Leena Leskelä Miika Linna Suvi Mäklin Jukka-Pekka Mecklin Petri Bono Vesa Kataja Sakari Karjalainen

Acta Oncol 2018 Jul 16;57(7):983-988. Epub 2018 Feb 16.

d Cancer Society of Finland , Helsinki , Finland.

View Article and Find Full Text PDF
July 2018

Modularising outpatient care delivery: A mixed methods case study at a Finnish University Hospital.

Authors:
Katariina Silander Paulus Torkki Antti Peltokorpi Aino Lepäntalo Maija Tarkkanen Petri Bono Katariina Klintrup Minna Kaila

Health Serv Manage Res 2018 11 16;31(4):195-204. Epub 2018 Jan 16.

5 University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

View Article and Find Full Text PDF
November 2018

Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials.

Authors:
Neal D Shore Teuvo L Tammela Christophe Massard Petri Bono John Aspegren Mika Mustonen Karim Fizazi

Eur Urol Focus 2018 07 14;4(4):547-553. Epub 2017 Feb 14.

Institut Gustave Roussy, University of Paris Sud, Villejuif, France.

View Article and Find Full Text PDF
July 2018

Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Castration-resistant, CYP17 Inhibitor-naïve Prostate Cancer: Results from Extended Follow-up of the ARADES Trial.

Authors:
Karim Fizazi Christophe Massard Petri Bono Vesa Kataja Nicholas James Teuvo L Tammela Heikki Joensuu John Aspegren Mika Mustonen

Eur Urol Focus 2017 12 27;3(6):606-614. Epub 2017 Feb 27.

Orion Corporation, Orion Pharma, Espoo, Finland.

View Article and Find Full Text PDF
December 2017

Cancer costs and outcomes in the Finnish population 2004-2014.

Authors:
Paulus Torkki Riikka-Leena Leskelä Miika Linna Suvi Mäklin Jukka-Pekka Mecklin Petri Bono Vesa Kataja Sakari Karjalainen

Acta Oncol 2018 Feb 11;57(2):297-303. Epub 2017 Jul 11.

c Cancer Society of Finland , Helsinki , Finland.

View Article and Find Full Text PDF
February 2018

Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.

Authors:
Heikki Joensuu Pirkko-Liisa Kellokumpu-Lehtinen Riikka Huovinen Arja Jukkola-Vuorinen Minna Tanner Riitta Kokko Johan Ahlgren Päivi Auvinen Outi Lahdenperä Sanna Kosonen Kenneth Villman Paul Nyandoto Greger Nilsson Paula Poikonen-Saksela Vesa Kataja Jouni Junnila Petri Bono Henrik Lindman

JAMA Oncol 2017 Jun;3(6):793-800

Uppsala University Hospital, Uppsala, Sweden.

View Article and Find Full Text PDF
June 2017

Correlation of c-Met Expression and Outcome in Patients With Renal Cell Carcinoma Treated With Sunitinib.

Authors:
Katriina Johanna Peltola Patrick Penttilä Juhana Rautiola Heikki Joensuu Erkki Hänninen Ari Ristimäki Petri Bono

Clin Genitourin Cancer 2017 08 1;15(4):487-494. Epub 2017 Feb 1.

Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland. Electronic address:

View Article and Find Full Text PDF
August 2017

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-induced Hypertension in Metastatic Renal Cell Carcinoma.

Authors:
Patrick Penttilä Juhana Rautiola Tuija Poussa Katriina Peltola Petri Bono

Clin Genitourin Cancer 2017 06 22;15(3):384-390.e3. Epub 2016 Dec 22.

Comprehensive Cancer Center, Helsinki University Central Hospital, Helsinki, Finland.

View Article and Find Full Text PDF
June 2017

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.

Authors:
Padmanee Sharma Margaret K Callahan Petri Bono Joseph Kim Pavlina Spiliopoulou Emiliano Calvo Rathi N Pillai Patrick A Ott Filippo de Braud Michael Morse Dung T Le Dirk Jaeger Emily Chan Chris Harbison Chen-Sheng Lin Marina Tschaika Alex Azrilevich Jonathan E Rosenberg

Lancet Oncol 2016 Nov 9;17(11):1590-1598. Epub 2016 Oct 9.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article and Find Full Text PDF
November 2016

Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy.

Authors:
Sara V Tornberg Harry Nisen Harri Visapää Tuomas P Kilpeläinen Riikka Järvinen Tuomas Mirtti Ilkka Kantonen Jarmo Simpanen Petri Bono Kimmo Taari Petrus Järvinen

Scand J Urol 2016 Oct;50(5):380-6

a Department of Urology , Helsinki University Hospital , Helsinki , Finland ;

View Article and Find Full Text PDF
October 2016